The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Increase In Market Value Is Predicted For The Connected Drug Delivery Devices Market During The 2026–2030 Period?
The connected drug delivery devices market has seen substantial expansion in recent years. It is projected to expand from $9.27 billion in 2025 to $11.48 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 23.8%. This historical growth is primarily driven by the increasing adoption of chronic disease management devices, a rising prevalence of diabetes and respiratory disorders, technological advancements in smart syringes and inhalers, growing healthcare digitization initiatives, and heightened awareness about medication adherence.
The connected drug delivery devices market is set for substantial growth in the coming years, with expectations to reach a valuation of $27.02 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.9%. This expansion throughout the forecast period is fueled by an increasing demand for remote patient monitoring, the evolution of connected healthcare ecosystems, the integration of AI-based predictive analytics, the proliferation of wearable drug delivery devices, and supportive government initiatives encouraging digital health adoption. Noteworthy trends during this period are expected to include personalized medication adherence monitoring, advanced remote patient monitoring solutions, seamless integration with electronic health records (EHR), data-driven dose optimization strategies, and real-time alerts and notifications.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp
What Primary Factors Are Fueling The Expansion Of The Connected Drug Delivery Devices Market?
The growing significance of remote patient monitoring is anticipated to drive the future expansion of the connected drug delivery device market. Remote patient monitoring is defined as a healthcare delivery strategy that employs technology to remotely monitor patients’ health and medical data. Connected drug delivery devices enhance this by facilitating precise tracking of medication usage and adherence, allowing for timely interventions, and enabling personalized care management. For example, in May 2024, the Journal of Medical Internet Research, a Canada-based peer-reviewed journal, reported that 38.78% of US adults had engaged with telehealth services during the previous year. Thus, the increasing relevance of remote patient monitoring is a key factor propelling the growth of the connected drug delivery device market.
How Is Segment Classification Applied In The Connected Drug Delivery Devices Market?
The connected drug delivery devices market covered in this report is segmented –
1) By Type: Standalone Components And Software, Integrated Devices
2) By Technology: Bluetooth, Near-Field Communication (NFC), Other Technologies
3) By Administration: Parenteral, Inhalational
4) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Diabetes Management, Other Applications
Subsegments:
1) By Standalone Components And Software: Mobile Applications, Connectivity Modules, Data Analytics Software
2) By Integrated Devices: Smart Inhalers, Smart Auto-injectors, Connected Syringes, Wearable Drug Delivery Devices
What Trends Are Affecting The Growth Of The Connected Drug Delivery Devices Market?
Leading companies in the connected drug delivery devices market are prioritizing the launch of sophisticated, more durable, and highly integrated digital health solutions. These solutions aim to improve treatment ease, increase monitoring precision, and ensure smooth connectivity with automated therapy systems. As an illustration, in November 2025, Dexcom, a US-based healthcare company, announced the launch of its new G7 15 Day continuous glucose monitor in the U.S. on December 1, 2025, intended for adults with diabetes. This device, having recently secured FDA clearance, will be the longest-wearing CGM available, allowing up to 15.5 days of use with an improved accuracy MARD of 8%. When it debuts, it will be obtainable through DME providers and eligible for coverage for Medicare users. The refined sensor is designed to integrate with the iLet Bionic Pancreas, Omnipod 5, and soon Tandem pumps, also supporting Dexcom’s new Smart Basal insulin optimization system. With less frequent sensor replacements, a waterproof construction, smartwatch integration, and simplified logging features, the G7 15 Day is engineered to deliver enhanced convenience and more effective long-term glucose management.
Who Are The Leading Firms Participating In The Connected Drug Delivery Devices Market?
Major companies operating in the connected drug delivery devices market are Pfizer Inc., Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Eli Lilly and Company, Novo Nordisk A/S, Becton Dickinson and Company, Phillips-Medisize Corporation, AptarGroup Inc., Dexcom Inc., West Pharmaceutical Services Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Meridian Medical Technologies LLC, Propeller Health, Findair Sp. z.o.o, Omron Healthcare Co. Ltd, Omnicell Inc., BD Medical
Access The Complete Connected Drug Delivery Devices Market Report:
Which Region Accounts For The Highest Share Of The Connected Drug Delivery Devices Market?
North America was the largest region in the connected drug delivery market in 2025. The regions covered in the connected drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Connected Drug Delivery Devices Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=13962&type=smp
Browse Through More Reports Similar to the Global Connected Drug Delivery Devices Market 2026, By The Business Research Company
Connected Drug Delivery Devices Market Report 2026
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model